Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Evolus, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 104 | 118 | +14 |
| Shares | 20.6M | 24.0M | +3.39M (+16.5%) |
| Value | $133.1M | $266.3M | +$133.1M (+100.0%) |
New holders (27)
Institutions that held Evolus, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (13)
Institutions that held Evolus, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 144,908 | $943.0K |
| Norges Bank | 52,700 | $343.0K |
| NinePointTwo Capital | 50,136 | $326.0K |
| Aristides Capital LLC | 32,004 | $208.0K |
| Engineers Gate Manager LP | 25,455 | $166.0K |
| Dynamic Technology Lab Private Ltd | 18,043 | $117.0K |
| Jump Financial, LLC | 17,700 | $115.0K |
| XTX Topco Ltd | 15,453 | $101.0K |
| HSBC Holdings PLC | 10,561 | $69.0K |
| Creative Planning | 10,046 | $65.0K |
| Vanguard Capital Wealth Advisors | 10,000 | $65.0K |
| State of Wyoming | 2,103 | $14.0K |
| Masso Torrence Wealth Management Inc. | 500 | $3.00K |